Future Outlook And Stock Price Performance For Better Therapeutics Inc. (NASDAQ: BTTX)

view original post

In today’s recent session, 9.44 million shares of the Better Therapeutics Inc. (NASDAQ:BTTX) were traded. Most recently the company’s share price was $8.10, and it changed around $1.69 or 26.36% from the last close, which brings the market valuation of the company to $147.43M. BTTX at last check was trading at a discount to its 52-week high of $29.40, offering almost -262.96% off that amount. The share price’s 52-week low was $6.36, which indicates that the recent value has risen by an impressive 21.48% since then. We note from Better Therapeutics Inc.’s average daily trading volume that its 3-month average coming to 2.01 million.

Instantly BTTX has been showing a green trend so far today with a performance of 26.36% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 9.75 on Tuesday, 11/23/21 increased the stock’s daily price by 16.92%. The company’s shares are currently down -35.90% year-to-date, but still down -21.54% over the last five days. On the other hand, Better Therapeutics Inc. (NASDAQ:BTTX) is -33.02% down in the 30-day period.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

The consensus price target as assigned by Wall Street analysts is $21.00, which translates to bulls needing to increase their stock price by 61.43% from its current value. Analyst projections state that BTTX is forecast to be at a low of $21.00 and a high of $21.00. In order for the stock price to hit the forecast high, the stock would need to plunge -159.26% from its current level, while the stock would need to crash -159.26% from its current level to reach the projected low.

BTTX Dividends

Better Therapeutics Inc.’s next quarterly earnings report is expected to be released in December.

Better Therapeutics Inc. (NASDAQ:BTTX)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 69.19% of Better Therapeutics Inc. shares, and 21.80% of them are in the hands of institutional investors. The stock currently has a share float of 70.77%. Better Therapeutics Inc. stock is held by 30 institutions, with Sectoral Asset Management, Inc. being the largest institutional investor. By Sep 29, 2021, it held 6.17% of the shares, which is about 0.47 million shares worth $4.65 million.

MMCAP International, Inc. SPC, with 4.63% or 0.35 million shares worth $3.49 million as of Sep 29, 2021, holds the second largest percentage of outstanding shares.

>> 7 Top Picks for the Post-Pandemic Economy <<

First Tr Exchange Traded Fd-First Trust Merger Arbitrage Fd and First Tr Exchange Traded Fd-First Trust Multi-Strategy Fd were the top two Mutual Funds as of Jun 29, 2021. The former held 64700.0 shares worth $0.64 million, making up 0.86% of all outstanding shares. On the other hand, First Tr Exchange Traded Fd-First Trust Multi-Strategy Fd held roughly 3648.0 shares worth around $36188.0, which represents about 0.05% of the total shares outstanding.